arrow
A

Atsunori Tsuchiya

University of Yamanashi
H指数:28
被引数:3,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy profile of S-005151 (Redasemtide), in patients with chronic liver diseases: phase 2 trial

S-005151(Redasemtide)在慢性肝病患者中的安全性和有效性特征:2期试验

2026-05-090
OAAI
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy

慢性丙型肝炎病毒感染患者直接抗病毒治疗后,血清CXCL10水平治疗后与治疗前的比值可预测代偿期和失代偿期肝硬化患者的短期肝功能结局

2026-02-010
OAAI
Significance of Measuring Interferon-γ-Induced Protein-10 Levels in Patients Receiving Systemic Therapies for Unresectable Hepatocellular Carcinoma

测量干扰素-γ诱导蛋白-10水平在不适合手术切除的肝癌患者接受全身治疗中的意义

2026-01-010
PRE
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination

血清生长分化因子15可作为预测丙型肝炎病毒肝硬化患者病毒清除后预后的新型生物标志物

2025-09-180
OAAI
Risk Factors for the Exacerbation of Esophageal Varices in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma

不可切除性肝细胞癌患者接受阿替利珠单抗联合贝伐珠单抗治疗时食管静脉曲张恶化的危险因素

2025-09-010
PRE
Analysis of distribution, collection, and confirmation of capacity dependency of small extracellular vesicles toward a therapy for liver cirrhosis
2023-10-096
OAAI